Hope for melanoma patients: New vaccine trial yields positive results
The first positive results from an mRNA-based cancer therapy for melanoma have been announced by Merck and Moderna, signalling a potential breakthrough in treatment.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on iol.co.za — the content belongs to IOL.